SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Wednesday 18 November 2026
News from the 24 hours to Wednesday morning, 18 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage focused on Smith & Nephew's simpler strategy, alongside commentary on its last buyback tranche and its appeal as a watchlist name. The tone leans modestly positive, driven mainly by the strategy update.
What drove it
- simpler strategy
- final buyback tranche
- investor watchlist interest
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Thu 12 Nov | +0.8 | 5 |
| Fri 13 Nov | −5.7 | 3 |
| Sat 14 Nov | 0.0 | 1 |
| Tue 17 Nov | +2.0 | 2 |
| Wed 18 Nov | +4.8 | 3 |
1 story · 3 headlines · strongest first
Pharma and healthcare on 18 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew market watch commentary +2.53 headlines today · 7 in all, since 12 November · Commentary pieces discuss the strategy, watchlist status and final buyback tranche. | ||
| +5.8 | Company announces a streamlined strategic plan, viewed as a constructive step.} | |
| +3.7 | Commentary on the company's improving appeal to investors, though speculative and light.} | |
| +3.0 | Company is completing a share repurchase programme, mildly supportive for shareholders.} | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.